Literature DB >> 19104009

Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.

Adriana Renzoni1, William L Kelley, Christine Barras, Antoinette Monod, Elzbieta Huggler, Patrice François, Jacques Schrenzel, René Studer, Pierre Vaudaux, Daniel P Lew.   

Abstract

Endogenous, low-level glycopeptide resistance in Staphylococcus aureus results from multifactorial genetic changes. Comparative genomic hybridization analysis revealed the specific deletion of a 1.8-kb segment encompassing two adjacent open reading frames (ORFs) of unknown function in a teicoplanin-susceptible revertant (strain 14-4rev) compared to the sequence of its isogenic, teicoplanin-resistant parental strain, strain 14-4. This provocative finding prompted us to perform a detailed genetic analysis of the contribution of this genomic segment to glycopeptide resistance. Despite repeated efforts in our laboratory, 14-4 and 14-4rev have proven refractory to most genetic manipulations. To circumvent this difficulty, we evaluated the contribution of both putative ORFs (designated teicoplanin resistance factors trfA and trfB) on teicoplanin resistance in a different, genetically tractable background. Genetic analysis showed that single or double trfA and/or trfB mutations abolished teicoplanin resistance in two independent teicoplanin-resistant derivatives of NCTC8325 strain ISP794 generated by two-step passages with the drug. The frequency of teicoplanin-resistant mutants was markedly decreased by the absence of trfAB in the teicoplanin-susceptible ISP794 background. Nevertheless, a low rate of teicoplanin-resistant mutants was selected from ISP794 trfAB, thus indicating an additional contribution of trfAB-independent pathways in the emergence of low-level glycopeptide resistance. Further experiments performed with clinical glycopeptide-intermediate S. aureus isolate NRS3 indicated that the trfAB mutation could affect not only teicoplanin resistance but also vancomycin and oxacillin resistance. In conclusion, our study demonstrates the key role of two novel loci in endogenous, low-level glycopeptide resistance in S. aureus whose precise molecular functions warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104009      PMCID: PMC2650575          DOI: 10.1128/AAC.01287-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  SarS, a SarA homolog repressible by agr, is an activator of protein A synthesis in Staphylococcus aureus.

Authors:  A L Cheung; K Schmidt; B Bateman; A C Manna
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the stability of a repressor.

Authors:  E Krüger; D Zühlke; E Witt; H Ludwig; M Hecker
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

3.  Teicoplanin stress-selected mutations increasing sigma(B) activity in Staphylococcus aureus.

Authors:  M Bischoff; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Authors:  M Kuroda; T Ohta; I Uchiyama; T Baba; H Yuzawa; I Kobayashi; L Cui; A Oguchi; K Aoki; Y Nagai; J Lian; T Ito; M Kanamori; H Matsumaru; A Maruyama; H Murakami; A Hosoyama; Y Mizutani-Ui; N K Takahashi; T Sawano; R Inoue; C Kaito; K Sekimizu; H Hirakawa; S Kuhara; S Goto; J Yabuzaki; M Kanehisa; A Yamashita; K Oshima; K Furuya; C Yoshino; T Shiba; M Hattori; N Ogasawara; H Hayashi; K Hiramatsu
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

5.  Microarray analysis of the Bacillus subtilis K-state: genome-wide expression changes dependent on ComK.

Authors:  Randy M Berka; Jeanette Hahn; Mark Albano; Irena Draskovic; Marjan Persuh; Xianju Cui; Alan Sloma; William Widner; David Dubnau
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

6.  SvpA, a novel surface virulence-associated protein required for intracellular survival of Listeria monocytogenes.

Authors:  E Borezée; E Pellegrini; J L Beretti; P Berche
Journal:  Microbiology       Date:  2001-11       Impact factor: 2.777

Review 7.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

8.  Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features.

Authors:  Olivier Denis; Claire Nonhoff; Baudouin Byl; Christiane Knoop; Sophie Bobin-Dubreux; Marc J Struelens
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

9.  Multiple pathways of Spx (YjbD) proteolysis in Bacillus subtilis.

Authors:  Shunji Nakano; Guolu Zheng; Michiko M Nakano; Peter Zuber
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

10.  Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus.

Authors:  Benjamin P Howden; Timothy P Stinear; David L Allen; Paul D R Johnson; Peter B Ward; John K Davies
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

View more
  21 in total

1.  Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus.

Authors:  Mélanie Roch; Perrine Clair; Adriana Renzoni; Marie-Elisabeth Reverdy; Olivier Dauwalder; Michèle Bes; Annie Martra; Anne-Marie Freydière; Frédéric Laurent; Philippe Reix; Oana Dumitrescu; François Vandenesch
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.

Authors:  William L Kelley; Ambre Jousselin; Christine Barras; Emmanuelle Lelong; Adriana Renzoni
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

Review 3.  Regulation of virulence and antibiotic resistance in Gram-positive microbes in response to cell wall-active antibiotics.

Authors:  Jessica J Evans; Devin D Bolz
Journal:  Curr Opin Infect Dis       Date:  2019-06       Impact factor: 4.915

4.  VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.

Authors:  Yuanyuan Dai; Wenjiao Chang; Changcheng Zhao; Jing Peng; Liangfei Xu; Huaiwei Lu; Shusheng Zhou; Xiaoling Ma
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

5.  Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.

Authors:  Miki Matsuo; Tomomi Hishinuma; Yuki Katayama; Longzhu Cui; Maria Kapi; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

6.  Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.

Authors:  Elena Galbusera; Adriana Renzoni; Diego O Andrey; Antoinette Monod; Christine Barras; Paolo Tortora; Alessandra Polissi; William L Kelley
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

7.  Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.

Authors:  Jae Il Yoo; Jung Wook Kim; Gi Su Kang; Hwa Su Kim; Jung Sik Yoo; Yeong Seon Lee
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

8.  The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance.

Authors:  Ambre Jousselin; William L Kelley; Christine Barras; Daniel P Lew; Adriana Renzoni
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 9.  Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus.

Authors:  Adriana Renzoni; William L Kelley; Pierre Vaudaux; Ambrose L Cheung; Daniel P Lew
Journal:  Trends Microbiol       Date:  2009-12-11       Impact factor: 17.079

10.  Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR.

Authors:  Yoshihisa Kato; Takahisa Suzuki; Takashi Ida; Kazunori Maebashi
Journal:  J Antimicrob Chemother       Date:  2010-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.